Aramsogo
FULL MEMBER
- Joined
- Feb 1, 2011
- Messages
- 1,906
- Reaction score
- -2
Reuters:
The Bayer ruling is likely to unnerve international pharmaceutical companies that see emerging markets like India as a major growth opportunity, but remain worried about intellectual property protection in such countries.
UPDATE 6-Pfizer scraps insulin deal with India's Biocon
The Bayer ruling is likely to unnerve international pharmaceutical companies that see emerging markets like India as a major growth opportunity, but remain worried about intellectual property protection in such countries.
UPDATE 6-Pfizer scraps insulin deal with India's Biocon